Original price was: ₹89.60.₹63.00Current price is: ₹63.00.
OMNITROL 20 H
Salt Composition: Olmesartan Medoxomil 20 mg & Hydrochlorothiazide 12.5 mg (tablet, alu-alu blister).
Brand: Leeford
10.0 tablets in 1 strip
Description
OMNITROL 20 H is a fixed-dose combination antihypertensive tablet containing olmesartan (an angiotensin II receptor blocker) and hydrochlorothiazide (a thiazide diuretic). This two-drug regimen is prescribed for patients whose blood pressure is not adequately controlled by monotherapy, providing a balanced approach to reducing blood pressure and lowering the risk of cardiovascular complications.
Clinical Uses
-
Management of high blood pressure (hypertension) in adults, especially when single-drug therapy is insufficient.
-
Reduces risk of stroke, heart attack, and kidney-related events associated with uncontrolled hypertension.
Mechanism of Action
-
Olmesartan selectively blocks angiotensin II receptors, causing blood vessels to relax and widen, which lowers blood pressure.
-
Hydrochlorothiazide acts as a diuretic, helping the body eliminate excess salt and water through urine, further reducing blood pressure.
Dosage & Administration
-
Take once daily at the same time each day, with or without food, as prescribed.
-
Swallow whole with water; avoid missing doses and do not stop abruptly without medical advice.
Common Side Effects
-
Headache, dizziness, weakness, tiredness, chest pain, swelling of the legs, ankles, or hands, increased urination, or muscle cramps.
-
Most side effects are mild and resolve on continued use; seek medical help for persistent or severe symptoms.
Precautions & Safety Advice
-
Not for use in pregnancy, severe kidney or liver impairment, allergy to sulfonamides, or certain metabolic disturbances (low potassium/sodium).
-
Regular monitoring of blood pressure, electrolytes, and kidney function is recommended.
-
Inform the doctor about all current medications to avoid interactions.
OMNITROL 20 H is an effective dual-component option for controlling hypertension and reducing cardiovascular risks.